Just curious
@Quest09, which weak hands are you referring to?
Just to be clear, I am long term bullish that Febridx will take off and do what we expect, coupled with the FFN stuff.
However, at what point do we look at face value of the book and determine actuality?
LDX as a share price has had every opportunity the last 12-18 months to go for a run. Outside of the well established PVM sell off, what else is there which could realistically be holding this down?
Weak hands? Or frustrated people shifting funds to more short term profitable stocks.
You could have taken $10,000 from LDX last Monday and popped it into SIG for an easy 30% on Thurs/Fri last week and still popped it back into LDX for a lower point than what you sold it for.
Tenmile have bought in huge at .038c. They are not going to "top up" on the dip. Why would they? It would take millions for their average to drop lower.
RYD aren't going to pump more in on market at this price, if they were, the would have done it when it was sub .03c last time.
LDX is
reliant on retail holders being interested enough to buy in here and it simply isn't being sold in "dumbass speak" for people to buy in currently.
If there is no news this week, we are back to the 52 week low.
The company needs to break down:
- What their current deals are and what they are worth in real terms / time frame
- What future opportunities are being targeted outside of what we know
- When the payments for Hologic are received/in hand and what progress there is on that front.
- When the f* they are starting this trial. Its already been a month or so since they obtained the funding for this. How long does it take to get a trial off the ground if they have anticipated this since development of the test! Lesser to that, 12 months preparation!
Also, not sure if anyone saw this:
